RhAPP Digital
From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs
The Hidden Costs: Obesity’s Role in Suboptimal Outcomes and Healthcare Burden in IMIDs
Podcast: Obesity and IMIDs: Unpacking the Epidemic and Its Far-Reaching Impacts
Live from RhAPP National: ILD & PH-ILD at the Rheum–Pulm Crossroads
RhAPPcast: ANCA-Associated Vasculitis: Insights From the RhAPP National Conference
FAQ: What Is the Clinical Significance of Structural Damage in PsA?
Med Review: Evidence for Guselkumab in Preventing Structural Damage Progression
FAQ: What is the Inflation Reduction Act & How Does It Impact Affordability of Biologic Therapies?
FAQ: What is the Effect of Guselkumab on Structural Damage in PsA?
RhAPPcast: Beyond Dryness: Key Takeaways from the Sjögren’s Symposium at RhAPP 2025
RhAPP National 2025 Day 2 Roundup
RhAPP National 2025 Day 3 Roundup
RhAPP National 2025 Day 1 Roundup
RhAPPcast: Unmasking XLH: Misdiagnosed and Misunderstood
RhAPPcast: Refractory PMR: When Steroids Aren’t Enough – Unmet Needs in Treatment
RhAPPcast: The Safety Conversation: Upadacitinib in the Treatment of GCA
Medication Review: What is the safety profile of sarilumab in PMR & RA?
RhAPPing it up!
What a start! 🙌 Day 1 of #RhAPP2025 brought incredible sessions
RhAPPcast: Expanding the Arsenal: JAK Inhibitors in the Evolving GCA Landscape
Medication Review: How is Sarilumab Dosed & Administered for the Treatment of PMR & RA?
Medication Review: Key Patient Education When Starting Sarilumab for PMR or RA
RhAPPcast: Inside the Evidence: A Deep Dive into the SELECT-GCA Study
RhAPPcast: Laying the Foundation: Historical Approaches to GCA Treatment
FAQ: What is the Role of Sarilumab in Managing PMR?
Sarilumab vs. Methotrexate as a Corticosteroid-Sparing Agent in Patients with Polymyalgia Rheumatica
FAQ: Choosing Between Steroid-Sparing Agents in PMR Treatment
Medication Review: Leflunomide Medication Review
RhAPPcast: Spotting the Signs: Recognizing and Diagnosing Giant Cell Arteritis
RhAPPcast: Foundations of PMR: Diagnosis, First-Line Therapy, and Tapering Strategies